Best Canadian Stocks to Buy With $7,000 Right Now

Investing in undervalued Canadian stocks such as West Fraser Timber should help you deliver outsized returns over the next three years.

Key Points
  • Aurinia Pharmaceuticals, a biopharmaceutical company focused on treating autoimmune diseases, reported strong growth, with LUPKYNIS sales up 27% year over year, prompting an increase in revenue guidance and highlighting its robust commercial momentum and liquidity for future R&D investments.
  • Analysts project Aurinia's revenue and free cash flow to increase significantly by 2029, potentially offering an 80% stock gain over the next three years if appropriately valued, driven by continued focus on high-volume prescribers and treatment guideline updates.
  • West Fraser Timber, down 28% from all-time highs, is navigating a challenging lumber market through strategic production cuts; analysts forecast a turnaround with 45% stock gains over three years, with cumulative returns potentially reaching 50% with dividends reinvested.

Investing in high-quality stocks poised to steadily increase free cash flow (FCF) is a proven strategy for generating outsized returns over time. In this article, I have identified two such Canadian stocks you can buy with $7,000 right now.

Source: Getty Images

Is this Canadian stock a good buy?

Valued at a market cap of almost US$2 billion, Aurinia Pharmaceuticals (NASDAQ: AUPH) is a biopharmaceutical company that delivers therapies to people living with autoimmune diseases. It offers LUPKYNIS (voclosporin), an oral therapy that treats adult patients with active lupus nephritis.

Aurinia Pharmaceuticals reported strong third-quarter results with LUPKYNIS sales climbing 27% year over year to US$70.6 million. Its solid numbers prompted management to raise full-year revenue guidance for the second time in 2025.

The company now expects net product sales of US$265 million to US$270 million, up from its previous guidance of US$250 million to US$260 million, demonstrating continued commercial momentum for its lupus nephritis treatment.

Net income surged 119% to US$31.6 million while diluted earnings per share jumped 130% to US$0.23 compared to the prior-year period. Operating cash flow more than doubled to US$44.5 million, which indicates improving profit margins. With more than US$350 million in cash, Aurinia has the liquidity to reinvest in research and development and organic growth.

Growth drivers include a sharper commercial focus on high-volume rheumatology prescribers and continued tailwinds from the American College of Rheumatology’s 2024 lupus nephritis treatment guidelines.

Analysts tracking the biotech stock forecast revenue to increase from US$235 million in 2024 to US$468 million in 2029. In this period, free cash flow is projected to improve from US$44.11 million to US$175 million. If Aurinia stock is priced at 20 times forward FCF, it could gain 80% over the next three years.

Is this Canadian stock undervalued?

Down 28% from all-time highs, West Fraser Timber (TSX: WFG) is a diversified wood products company. Its products are sold to major retail chains, contractor supply yards, wholesalers, and industrial customers for further processing or as components for other products.

In Q3 2025, West Fraser Timber reported negative adjusted EBITDA (earnings before interest, tax, depreciation, and amortization) of $144 million as the lumber industry continues to wrestle with an extended downturn.

It faced headwinds from stagnant U.S. housing starts, which averaged just 1.31 million units through August. The housing sector is held back by elevated mortgage rates that continue to dampen affordability and new home construction.

West Timber has been proactive in addressing the prolonged slump, permanently removing 820 million board feet of capacity since 2022 through mill closures across the U.S. and Canada. That represents about 12% of total lumber capacity before the cuts. Current operating rates reflect a roughly 20% to 25% curtailment of remaining capacity as management adjusts production to match tepid demand.

Analysts tracking the TSX stock forecast the company to end 2029 with free cash flow of $912 million, compared to an outflow of $322.7 million in 2025.

If West Timber stock is priced at 12 times forward FCF, which is reasonable, it could gain 45% over the next three years. If we account for dividend reinvestments, cumulative returns could be closer to 50%.

Fool contributor Aditya Raghunath has no position in any of the stocks mentioned. The Motley Fool recommends West Fraser Timber. The Motley Fool has a disclosure policy.

More on Dividend Stocks

Blocks conceptualizing Canada's Tax Free Savings Account
Dividend Stocks

TFSA Strategy: How to Earn $500 a Month in Tax-Free Dividend Income

Canadians can earn $500 in tax-free dividend income or another desired amount every month using a simple TFSA strategy.

Read more »

doctor uses telehealth
Dividend Stocks

TFSA Investors: This Monthly Dividend Stock Yields 7.6%

This REIT offers investors a monthly yield investors and a regular and frequent passive income stream to supplement their regular…

Read more »

shopper chooses vegetables at grocery store
Dividend Stocks

Loblaw vs. Empire: Which Grocery Stock Would I Choose for Long-Term Growth?

Both grocers benefit from repeat shoppers. I’d give Loblaw the edge for the ways it can earn more from those…

Read more »

ETF is short for exchange traded fund, a popular investment choice for Canadians
Dividend Stocks

2 Top TSX ETFs to Buy and Hold in a TFSA Forever

Looking for top TSX ETFs for your TFSA? Explore how VFV and VDY combine U.S. stock exposure and Canadian dividends…

Read more »

Retirees sip their morning coffee outside.
Dividend Stocks

2 Canadian Stocks to Buy and Hold for 20 More Years

CP Rail (TSX:CP) and another outstanding Canadian stock that's more than worth holding for many decades.

Read more »

woman relaxes with phone
Dividend Stocks

Is TELUS Stock a Buy for Its 6% Dividend Yield?

TELUS's attractive 6% dividend yield and ongoing business transformation could offer patient investors an opportunity to benefit from income and…

Read more »

middle-aged couple work together on laptop
Dividend Stocks

Dividend Income Outside a TFSA? The OAS Math I’d Check Before Buying More

A $1,000 dividend can add $1,380 to the income used to calculate your Old Age Security recovery tax.

Read more »

Colored pins on calendar showing a month
Dividend Stocks

Monthly Dividend Stocks: 3 TSX Picks That Pay Every 30 Days

These monthly dividend stocks stand out for their strong distribution history and ability to sustain payouts in the years ahead.

Read more »